55513-123 : Tezspire 210 mg/1.9ml Subcutaneous Injection, Solution
NDC: | 55513-123 |
Labeler: | Amgen, Inc |
Product Type: | Human Prescription Drug |
Drug Name: | Tezspire |
Dosage Form: | Subcutaneous Injection, Solution |
Application #: | BLA761224 |
Rev. Date: |
NDC Package Codes:
- 55513-123-01: 1 CARTRIDGE IN 1 CARTON (55513‑123‑01) / 1.91 ML IN 1 CARTRIDGE
- 55513-123-96: 1 CARTRIDGE IN 1 CARTON (55513‑123‑96) / 1.91 ML IN 1 CARTRIDGE
Active Ingredients:
- Tezepelumab
Dosage Strength:
- 210 mg/1.9mL
Pharmaceutical Classes:
- Thymic Stromal Lymphopoietin Blocker [EPC]
- Thymic Stromal Lymphopoietin Blockers [MoA]
Related Products:
Based on records with the same trade name.- 55513-100 Tezspire 210 mg/1.9ml Subcutaneous Injection, Solution by Amgen, Inc
- 55513-112 Tezspire 210 mg/1.9ml Subcutaneous Injection, Solution by Amgen, Inc
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 55513-112Next: 55513-126 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.